OTHER INFORMATION REQUIRED FOR EFFECTIVE DRUG MONITORING

OTHER INFORMATION REQUIRED FOR EFFECTIVE DRUG MONITORING is a topic covered in the Guide to Diagnostic Tests.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Reliability of the Analytic Method

The analytic sensitivity of the drug monitoring method must be adequate. For some drugs, plasma levels are in the nanogram per milliliter range. Example: Tricyclic antidepressants, digoxin.

The specificity of the method must be known, because the drug’s metabolites or other drugs may interfere. Interference by metabolites, which may or may not be pharmacologically active, is of particular concern in immunologic assay methods using antibodies to the parent drug.

The precision of the method must be known to assess whether changes in levels are caused by method imprecision or by clinical changes.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - OTHER INFORMATION REQUIRED FOR EFFECTIVE DRUG MONITORING ID - 619575 A1 - Lu,Chuanyi Mark, AU - McPhee,Stephen J, AU - Nicoll,Diana, BT - Guide to Diagnostic Tests UR - https://im.unboundmedicine.com/medicine/view/GDT/619575/all/OTHER_INFORMATION_REQUIRED_FOR_EFFECTIVE_DRUG_MONITORING PB - McGraw-Hill Education ET - 7 DB - Medicine Central DP - Unbound Medicine ER -